Pacira BioSciences Inc (PCRX)

Industry Drug Manufacturers - Specialty & Generic

This stock can be held in an Investment ISA and an Investment Account

Sell

$15.77

Buy

$27.25

arrow-down$-0.13 (-0.55%)

Prices updated at 22 May 2026, 22:36 EDT

Prices minimum 15 mins delay

Prices in USD

Pacira Pharmaceuticals Inc is a specialty and generic drug manufacturing company. The company develops, manufactures, and commercializes pharmaceutical products for use in hospitals and ambulatory surgery centers across the United States.

NASDAQ

0.19%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Chairman

Ms. Laura A. Brege

CEO

Mr. Frank D. Lee

Most recent earnings

31 Dec 2025

Fiscal year end

31 Dec 2025

Employees

829

Head office

2000 Sierra Point Parkway

Brisbane

United States

94005

+1 650 242-8052

Susan.Mesco@pacira.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Dr. Samit Hirawat, M.D. Independent Director	-
Ms. Laura A. Brege Chairman of the Board	0.09m
Ms. Lauren Riker Principal Accounting Officer and Senior Vice President, Finance	0.37m
Dr. Mark A. Kronenfeld, M.D. Independent Director	0.09m
Mr. Michael J. Yang Independent Director	0.07m
Dr. Mark I. Froimson, M.D. Independent Director	0.07m
Mr. Abraham N. Ceesay, M.B.A. Independent Director	0.06m
Governor Christopher J. Christie Independent Director	0.05m
Mr. Shawn M. Cross Chief Financial Officer	0.10m
Mr. Frank D. Lee Director and Chief Executive Officer	0.90m
Mr. Brendan P. Teehan Chief Commercial Officer	-
Ms. Alethia Young Independent Director	0.07m
Mr. Daryl Gaugler Executive Vice President, Commercial Operations	0.51m
Dr. Marcelo Bigal, M.D.,PhD Independent Director	0.07m
Ms. Krys Corbett Chief Business Officer	-
Ms. Kristen Marie Williams Chief Administrative Officer and Secretary	0.52m
Mr. Jonathan Slonin Chief Medical Officer	0.54m

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
BlackRock Inc	7,064,280
Vanguard Group Inc	4,812,955
BlackRock Fund Advisors	4,409,955
Doma Perpetual Capital Management LLC	2,777,794
iShares Core S&P Small-Cap ETF	2,507,927

Director dealings

Date chevron-l-regular chevron-r-regular	Action
31 Dec 2025	-
09 Dec 2025	-
09 Dec 2025	-
09 Dec 2025	-
10 Dec 2025	-
10 Dec 2025	-
10 Dec 2025	-
17 Nov 2025	-
10 Nov 2025	-
31 Oct 2025	-
04 Sep 2025	-
07 Aug 2025	-
01 Aug 2025	-
11 Jun 2025	-
11 Jun 2025	-
11 Jun 2025	-
11 Jun 2025	-
11 Jun 2025	-
11 Jun 2025	-
11 Jun 2025	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.